AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitacip M 50/1000 Tablet ER

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitacip M 50/1000 Tablet ER

Diabex Duo 50/1000 Extended-Release tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, and may lessen the risk of stroke or heart attack. Diabex Duo may be used alone or with other diabetes treatments, and is most effective when coupled with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. For optimal results, take it consistently at the same time daily; discontinue only under your doctor's guidance. Adhering to your prescribed diet and exercise regimen is crucial for effective diabetes management. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when used with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't suitable for all. Inform your physician of any history of liver, kidney, or heart disease, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or nursing individuals should consult their doctor. Other medications can interact with Diabex Duo; disclose all medications to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood sugar levels throughout your treatment.

Uses of Sitacip M 50/1000 Tablet ER

Managing type 2 diabetes

Major Benefits of Sitacip M 50/1000 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sitacip M 50/1000 Tablet ER with a meal.

Common Side effects of Sitacip M 50/1000 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitacip M 50/1000 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Sitacip M 50/1000 Tablet ER with a meal.

How Sitacip M 50/1000 Tablet ER works:

Sitagliptin and metformin, the components of Sitacip M 50/1000 ER tablets, work synergistically to manage blood glucose. Sitagliptin enhances insulin secretion from the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This combined action results in superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitacip M 50/1000 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Sitacip M 50/1000 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sitacip M 50/1000 tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitacip M 50/1000 ER tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitacip M 50/1000 ER tablets. Physician consultation is necessary. Kidney function should be regularly monitored during treatment.

LiverLiverUNSAFE

Extended-release Sitacip M 50/1000 tablets pose a likely risk for individuals with hepatic impairment and are best avoided. Medical advice is recommended.

What if you forget to take Sitacip M 50/1000 Tablet ER :

Should you forget a dose of Sitacip M 50/1000 Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitacip M 50/1000 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitacip M 50/1000 Tablet ER

Sitacip M 50/1000 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitacip M 50/1000 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitacip M 50/1000 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitacip M 50/1000 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitacip M 50/1000 Tablet ER and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitacip M 50/1000 Tablet ER) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitacip M 50/1000 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitacip M 50/1000 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitacip M 50/1000 Tablet ER is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitacip M 50/1000 Tablet ER with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (Sitacip M 50/1000 Tablet ER) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitacip M 50/1000 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitacip M 50/1000 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitacip M 50/1000 Tablet ER may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitacip M 50/1000 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitacip M 50/1000 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitacip M 50/1000 Tablet ER) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sitacip M 50/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitacip M 50/1000 Tablet ...
113
MRP 131
13% off